Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Point72 Hyperscale is a venture capital firm founded in 2016 and based in the United States. The firm focuses on early-stage investments, supporting companies from seed to pre-IPO stages. They have backed over 130 companies across various sectors since inception.
Point72 Hyperscale invests in thematic-driven sectors, specifically Artificial Intelligence, Consumer, and Defense Technology. They target early-stage companies that utilize data to gain competitive advantages and assist brands in developing standout strategies in crowded markets.
Notable companies in Point72 Hyperscale's portfolio include Heidi Health, focused on consumer health; Fever, in the entertainment ecosystem; CX2, a defense technology investment; and Apex, another investment in defense technology.
Submit through their form at https://p72hyperscale.com.
Yes, Point72 Hyperscale often leads investment rounds, particularly in their focus sectors.
The firm is open to follow-on investments, especially for companies that demonstrate strong growth and alignment with their thematic focus.
Specific fund size details are not disclosed, but the firm has a significant capital base to support its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.